Virginia Retirement Systems Et Al Fate Therapeutics Inc Transaction History
Virginia Retirement Systems Et Al
- $10.1 Billion
- Q3 2023
A detailed history of Virginia Retirement Systems Et Al transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 42,300 shares of FATE stock, worth $71,064. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,300
Previous 33,600
25.89%
Holding current value
$71,064
Previous $159,000
44.03%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding FATE
# of Institutions
175Shares Held
115MCall Options Held
53.7KPut Options Held
9K-
Redmile Group, LLC San Francisco, CA13.2MShares$22.1 Million3.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.4MShares$17.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$17 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.57MShares$9.36 Million0.72% of portfolio
-
State Street Corp Boston, MA5.25MShares$8.82 Million0.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $163M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...